Ryotaro Yoshida
- Biological Psychiatry top 0.2%
- Immunology top 2%
- Behavioral Neuroscience top 0.5%
- Molecular Biology
- Psychiatry and Mental health top 5%
- Co-authors
- O HayaishiOsamu TakikawaOsamu HayaishiR. KidoT OkuHiroaki YasuiTsunataro KíshidaJirô Imanishi
- Topics
- Immune Cell Function and Interaction (29 papers)Immunotherapy and Immune Responses (23 papers)Tryptophan and brain disorders (20 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Ryotaro Yoshida
84 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 106
- Biological Psychiatry 1.2k
- Immunology 1.0k
- Behavioral Neuroscience 616
- Molecular Biology 603
- Psychiatry and Mental health 336
Countries citing papers authored by Ryotaro Yoshida
This map shows the geographic impact of Ryotaro Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryotaro Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryotaro Yoshida more than expected).
Fields of papers citing papers by Ryotaro Yoshida
This network shows the impact of papers produced by Ryotaro Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryotaro Yoshida. The network helps show where Ryotaro Yoshida may publish in the future.
Co-authorship network of co-authors of Ryotaro Yoshida
This figure shows the co-authorship network connecting the top 25 collaborators of Ryotaro Yoshida. A scholar is included among the top collaborators of Ryotaro Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryotaro Yoshida. Ryotaro Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 6 | |
| 6 | 8 | |
| 7 | 14 | |
| 8 | 5 | |
| 9 | 9 | |
| 10 | 30 | |
| 11 | 5 | |
| 12 | 11 | |
| 13 | 50 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | 21 | |
| 17 | 2 | |
| 18 | 73 | |
| 19 | 6 | |
| 20 | 100 |
About Ryotaro Yoshida
Ryotaro Yoshida is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Immunology, having authored 85 papers that have together received 2.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (29 papers), Immunotherapy and Immune Responses (23 papers) and Tryptophan and brain disorders (20 papers). The work is most often cited by research in Biological Psychiatry (1.2k citations), Behavioral Neuroscience (616 citations) and Immunology (1.0k citations). Ryotaro Yoshida has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include O Hayaishi, Osamu Takikawa, Osamu Hayaishi, R. Kido, T Oku, Hiroaki Yasui, Tsunataro Kíshida, Jirô Imanishi, Y. Urade and Yukio Yoneda. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.